GSK PLC-SPON ADR (GSK) Institutional Ownership Changes & 13F Activity
GSK PLC-SPON ADR (GSK). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Manufacturers Life Insurance Company, The, Citadel Advisors Llc, Public Employees Retirement System Of Ohio, Envestnet Asset Management Inc, and State Street Corp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Envestnet Asset Management Inc | Buy | +70,805 | +3.9% | 1,908,549 | $100.04M | Q2 2026 | Sep 23, 2026 |
| Qrg Capital Management, Inc. | Buy | +13,519 | +7.6% | 191,512 | $10.04M | Q2 2026 | Sep 23, 2026 |
| Envestnet Portfolio Solutions, Inc. | Buy | +585 | +3.3% | 18,135 | $950.66K | Q2 2026 | Sep 23, 2026 |
| State Street Corp | Sell | -39,371 | -0.7% | 5,959,115 | $315.14M | Q2 2026 | Sep 22, 2026 |
| Security National Bank Of So Dak | Buy | +728 | — | 728 | $38.16K | Q2 2026 | Sep 18, 2026 |
| Security National Bank Of Sioux City Iowa | Buy | +80 | — | 80 | $4.19K | Q2 2026 | Sep 18, 2026 |
| Anchor Investment Management, Llc | Sell | -7,100 | -21.2% | 26,340 | $1.38M | Q2 2026 | Sep 15, 2026 |
| Cherry Tree Wealth Management, Llc | Sell | -23 | -25.6% | 67 | $3.51K | Q2 2026 | Sep 15, 2026 |
| Manufacturers Life Insurance Company, The | Sell | -490,337 | -20.6% | 1,887,739 | $98.96M | Q2 2026 | Sep 09, 2026 |
| Integrated Wealth Concepts Llc | Sell | -2,406 | -10.1% | 21,322 | $1.12M | Q2 2026 | Sep 09, 2026 |
| Parkside Financial Bank & Trust | Buy | +75 | +4.2% | 1,841 | $96.51K | Q2 2026 | Sep 04, 2026 |
| Citadel Advisors Llc | Buy | +151,573 | — | 151,573 | $7.95M | Q2 2026 | Sep 02, 2026 |
| Parrish Capital Llc | Buy | +22 | +0.1% | 29,610 | $1.55M | Q2 2026 | Sep 01, 2026 |
| Cornerstone Financial Management Llc | Buy | +113 | +86.9% | 243 | $12.74K | Q2 2026 | Aug 28, 2026 |
| Corient Private Wealth Llc | Buy | +864 | +0.8% | 105,377 | $5.52M | Q2 2026 | Aug 27, 2026 |
| Cantor Fitzgerald, L. P. | Buy | +28,832 | — | 28,832 | $1.51M | Q2 2026 | Aug 19, 2026 |
| Kingsview Wealth Management, Llc | Buy | +2,892 | +23.0% | 15,451 | $809.92K | Q2 2026 | Aug 19, 2026 |
| Mercer Global Advisors Inc | Sell | -91 | -0.1% | 155,769 | $8.17M | Q2 2026 | Aug 19, 2026 |
| Beacon Pointe Advisors, Llc | Sell | -6,136 | -23.2% | 20,274 | $1.06M | Q2 2026 | Aug 18, 2026 |
| Jdm Financial Group Llc | Buy | +52 | — | 52 | $2.73K | Q2 2026 | Aug 18, 2026 |
| Pin Oak Investment Advisors Inc | Buy | +33 | — | 33 | $2.00 | Q2 2026 | Aug 18, 2026 |
| Public Employees Retirement System Of Ohio | Buy | +143,360 | +1202.4% | 155,283 | $8.14M | Q2 2026 | Aug 17, 2026 |
| United Capital Financial Advisors, Llc | Sell | -6,139 | -13.7% | 38,679 | $2.03M | Q2 2026 | Aug 17, 2026 |
| Pure Financial Advisors, Llc | Buy | +2,982 | +38.8% | 10,662 | $558.91K | Q2 2026 | Aug 17, 2026 |
| Kahn Brothers Group | Sell | -2,544 | -1.6% | 158,438 | $8.31M | Q2 2026 | Aug 17, 2026 |
| Dearborn Partners Llc | Buy | +1,750 | +8.2% | 23,142 | $1.21M | Q2 2026 | Aug 17, 2026 |
| Empowered Funds, Llc | Sell | -1,158 | -1.2% | 92,346 | $4.84M | Q2 2026 | Aug 17, 2026 |
| Equitable Holdings, Inc. | Buy | +1,011 | +1.5% | 66,889 | $3.51M | Q2 2026 | Aug 17, 2026 |
| Transamerica Financial Advisors, Llc | Sell | -801 | -16.2% | 4,132 | $218.45K | Q2 2026 | Aug 17, 2026 |
| Centaurus Financial, Inc. | Sell | -37 | -1.5% | 2,475 | $130.00K | Q2 2026 | Aug 17, 2026 |
Frequently asked questions about GSK activity
Which institutional owners are buying GSK?
Institutional owners buying GSK include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in GSK activity?
"Buy" means an investor increased their reported position in GSK compared to the prior reporting period. This reflects growing exposure to GSK PLC-SPON ADR (GSK) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in GSK increasing?
Institutional interest in GSK can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related GSK Institutional Insights
- GSK Overview
- GSK 13F Institutional Holders
- GSK Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GSK Insider Trading & SEC Form 4 Activity
- GSK Articles
- Top Institutional Investor Stock Rankings